Jubilant Ingrevia (JUBLINGREA) Fundamentals 2026 — P/E 42.3x, Revenue Analysis | SniperIQ
Jubilant Ingrevia (JUBLINGREA) is a India-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ₹11,730 Crore, trading at ₹742.75 on the BSE. This SniperIQ fundamentals page covers Jubilant Ingrevia's valuation (P/E 42.3x, P/B 3.8x), profitability (net margin 6.4%), revenue (₹4,388 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Jubilant Ingrevia's market cap?
Jubilant Ingrevia (JUBLINGREA) has a market capitalization of approximately ₹11,730 Crore, trading at ₹742.75 on the BSE. Market cap moves with the live share price.
What is Jubilant Ingrevia's P/E ratio?
Jubilant Ingrevia's trailing twelve-month P/E ratio is 42.3x, with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Jubilant Ingrevia?
Jubilant Ingrevia runs a net profit margin of 6.4%, a gross margin of 35.6%, and an operating margin of 9.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Jubilant Ingrevia generate?
Jubilant Ingrevia reported revenue of ₹4,388 Crore for fiscal year 2026, with net income of ₹278 Crore and earnings per share (EPS) of 17.59. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Jubilant Ingrevia pay a dividend?
Jubilant Ingrevia offers a trailing dividend yield of about 0.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Jubilant Ingrevia financially healthy?
Jubilant Ingrevia carries a debt-to-equity ratio of 0.25x and a current ratio of 1.29x, with a market beta of 0.29. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Jubilant Ingrevia a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Jubilant Ingrevia (JUBLINGREA) the key facts are: market cap ₹11,730 Crore, P/E 42.3x, revenue ₹4,388 Crore, 52-week range 535.3-845.95. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Jubilant Ingrevia's full fundamentals live
Get Jubilant Ingrevia's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.